Table 2.
Ref. | Year | Type of study | Indication | n | Follow-up (mo) | Technical success | Complications | Clinical success |
Janík et al[37] | 2011 | CS | PS | 3 | 5 | 100% | 0% | 66% |
Rejchrt et al[8] | 2009 | CS | Stricturing CD | 11 | 14 | 91% | Stent migration, 27% | 64% |
Toth et al[36] | 2011 | CR | PS | 1 | 5 | 100% | 0% | 100% |
Pérez Roldán et al[35] | 2012 | CS | PS and fistula | 10 | 13 | 90% | Stent migration, 10% | 50% |
Repici et al[34] | 2013 | CS | PS | 11 | 3 | 100% | Stent migration, 36% | 45% |
Rodrigues et al[39] | 2013 | CR | Stricturing CD | 1 | 16 | 100% | 0% | 100% |
CR: Case report; CS: Case series; RCT: Randomized clinical trial; CD: Crohn’s disease; PS: Postsurgical strictures.